Genomics Sells Nearly 30,000 Shares: Investor Signal for Genomics Stocks
A CEO’s large stock sale can spark questions about a company’s trajectory. This guide breaks down what genomics sells...
This guide weighs the advantages and drawbacks of target date versus lifecycle funds to help you pick the option that best fits your retirement plan.
25,428 articlesA CEO’s large stock sale can spark questions about a company’s trajectory. This guide breaks down what genomics sells...
As vernova's next earnings report approaches, traders and long-term investors weigh margin trends, project momentum, ...
Circle Inc.’s public shares jumped again on Tuesday as Bernstein maintained an upbeat view on the company, pointing t...
Markets react after macquarie downgrades paypal cost-saving plan, citing a back-loaded path to benefits. Investors fo...
When a company director trims a stake, investors ask: what does it mean for the stock? This guide walks you through h...
A Sunrun co-founder disclosed the sale of 50,000 shares, prompting questions about timing and implications. This arti...
With summer on the horizon, investors wonder if XLE should ride along in their portfolios. This guide weighs the case...
Inflation remains a stubborn backdrop, yet stocks are pushing higher. This article breaks down what’s driving the ral...
What really predicts wealth in America? This article explores whether the idea behind wanna rich? marry college holds...
A 34% year-to-date drop has investors wondering if Zscaler can stage a comeback. This deep dive breaks down the catal...
Thinking about buying your first rental property in 2026? This practical, step-by-step guide breaks down budgeting, f...
Investors face a decisive choice: lean into specialized aerospace parts with HEICO or embrace Textron’s diversified i...